Provided by Tiger Trade Technology Pte. Ltd.

Gain Therapeutics, Inc.

1.91
-0.0950-4.75%
Volume:366.31K
Turnover:720.91K
Market Cap:83.14M
PE:-3.74
High:2.05
Open:2.00
Low:1.90
Close:2.00
52wk High:4.34
52wk Low:1.53
Shares:43.64M
Float Shares:42.34M
Volume Ratio:1.13
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5092
EPS(LYR):-0.6115
ROE:-268.30%
ROA:-95.51%
PB:7.36
PE(LYR):-3.12

Loading ...

May 16, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2022

Major Issues Report

8-K - Current report
Dec 28, 2021

Major Issues Report

8-K - Current report
Aug 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Apr 06, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 22, 2021

Major Issues Report

8-K - Current report
Mar 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 15, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 10, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 19, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933